Inhaled Epoprostenol Use in Patients with SARS-CoV2-Related Severe Hypoxemic Respiratory Failure

Authors

  • Johnny Jaber Division of Pulmonary, Critical Care, and Sleep Medicine, University of Florida College of Medicine, Gainesville FL 32608
  • Hamza Alzghoul University of Central Florida College of Medicine, Graduate Medical Education 6850 Lake Nona Blvd, Orlando, FL, 32827, USA
  • Raju Reddy Division of Pulmonary and Critical Care Medicine, Oregon Health Sciences University, Portland OR 97239
  • Haneen Saker Division of Pulmonary, Critical Care, and Sleep Medicine, University of Florida College of Medicine, Gainesville FL 32608
  • Mohammad Almomani 6. Faculty of Medicine, Jordan University of Science and Technology, Irbid, 22110, Jordan
  • Haya kaseer Department of Pharmacy, UF health Shands Hospital, Gainesville, Florida
  • Bashar Alzghoul Division of Pulmonary, Critical Care, and Sleep Medicine, University of Florida College of Medicine, Gainesville FL 32608

DOI:

https://doi.org/10.58877/japaj.v1i3.58

Keywords:

Epoprostenol, SARS-CoV2, COVID-19, respiratory failure, ventilator, high flow nasal cannula, non-invasive positive pressure ventilation

References

Searcy RJ, Morales JR, Ferreira JA, Johnson DW. The role of inhaled prostacyclin in treating acute respiratory distress syndrome. Ther Adv Respir Dis. 2015;9(6):302-312. DOI: https://doi.org/10.1177/1753465815599345

Torbic H, Szumita PM, Anger KE, Nuccio P, LaGambina S, Weinhouse G. Inhaled epoprostenol vs inhaled nitric oxide for refractory hypoxemia in critically ill patients. J Crit Care. 2013;28(5):844-848. DOI: https://doi.org/10.1016/j.jcrc.2013.03.006

Fuller BM, Mohr NM, Skrupky L, Fowler S, Kollef MH, Carpenter CR. The use of inhaled prostaglandins in patients with ARDS: a systematic review and meta-analysis. Chest. 2015;147(6):1510-1522. DOI: https://doi.org/10.1378/chest.14-3161

Haeberle HA, Calov S, Martus P, et al. Inhaled prostacyclin therapy in the acute respiratory distress syndrome: a randomized controlled multicenter trial. Respir Res. 2023;24:58. DOI: https://doi.org/10.1186/s12931-023-02346-0

Kataria V, Ryman K, Tsai-Nguyen G, Wakwaya Y, Modrykamien A. Evaluation of aerosolized epoprostenol for hypoxemia in non-intubated patients with coronavirus disease 2019. Hosp Pract (1995). 2022;50(2):118-123. DOI: https://doi.org/10.1080/21548331.2022.2047310

Demoule A, Vieillard Baron A, Darmon M, et al. High-Flow Nasal Cannula in Critically III Patients with Severe COVID-19. Am J Respir Crit Care Med. 2020;202(7):1039-1042. DOI: https://doi.org/10.1164/rccm.202005-2007LE

Downloads

Published

2023-10-12

How to Cite

Jaber, J., Alzghoul, H., Reddy, R., Saker, H., Almomani, M., kaseer, H., & Alzghoul, B. (2023). Inhaled Epoprostenol Use in Patients with SARS-CoV2-Related Severe Hypoxemic Respiratory Failure. JAP Academy Journal, 1(3). https://doi.org/10.58877/japaj.v1i3.58

Issue

Section

Short Communications